Omega Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Omega Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2022 to Q3 2024.
  • Omega Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 253 %, a 50.5% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 253 -258 -50.5% Sep 30, 2024
Q2 2024 307 -340 -52.6% Jun 30, 2024
Q1 2024 346 -576 -62.5% Mar 31, 2024
Q4 2023 442 -636 -59% Dec 31, 2023
Q3 2023 511 -938 -64.8% Sep 30, 2023
Q2 2023 647 -957 -59.7% Jun 30, 2023
Q1 2023 922 -626 -40.4% Mar 31, 2023
Q4 2022 1.08K Dec 31, 2022
Q3 2022 1.45K Sep 30, 2022
Q2 2022 1.6K Jun 30, 2022
Q1 2022 1.55K Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.